跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CNS-3
首页
药物
CNS-3
CNS-3
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders
US 2007082940 A1
申请人: SKOLNICK PHIL
优先权: 2005
CN
US
12 件公开
3-PYRROLIDINE-INDOLE DERIVATIVES AS SEROTONERGIC PSYCHEDELIC AGENTS FOR THE TREATMENT OF CNS DISORDERS
EP 4100403 A4
申请人: MINDSET PHARMA INC
优先权: 2020
CN
EP
US
WO
8 件公开
INDOLE DERIVATIVES AS SEROTONERGIC AGENTS USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
EP 4301730 A1
申请人: MINDSET PHARMA INC
优先权: 2021
CN
EP
US
WO
8 件公开
Omega-3 pentaenoic acid compositions and methods of use
US 10058521 B2
申请人: MATINAS BIOPHARMA INC
优先权: 2013
US
8 件公开
DOSE REGIMENS FOR USE OF LY3154207 IN THE TREATMENT OF DOPAMINERGIC CNS DISORDERS
EP 3897578 B1
申请人: LILLY CO ELI
优先权: 2018
CN
EP
US
WO
6 件公开
3-(Heteroaryl-Oxy)-2-Alkyl-1-Aza-Bicycloalkyl Derivatives As Alpha. 7-Nachrligands For TheTreatment Of Cns Diseases
US 2008194573 A1
申请人: NOVARTIS AG
优先权: 2004
CN
EP
US
6 件公开
3,3 DISUBSTITUTED 19-NOR PREGNANE COMPOUNDS, COMPOSITIONS, AND USES THEREOF
EP 2766380 B1
申请人: SAGE THERAPEUTICS INC
优先权: 2011
CN
EP
US
6 件公开
Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders
US 7528262 B2
申请人: ATHERSYS INC
优先权: 2006
US
6 件公开
5-HT7 Receptor antagonists
EP 1676840 A1
申请人: ESTEVE LABOR DR
优先权: 2004
CN
EP
US
5 件公开
US 7553965 B2
申请人: ESTEVE LABOR DR
优先权: 2005
US
2 件公开
Acetylenyl-pyrazolo-pyrimidine derivatives
US 7238808 B2
申请人: HOFFMANN LA ROCHE
优先权: 2005
CN
US
5 件公开
第 1 / 10 页
上一页
下一页
药物
反馈